Jiangbing Xie - Eyebright Medical GM Chairman
| 688050 Stock | 90.61 1.90 2.05% |
Chairman
Jiangbing Xie is GM Chairman of Eyebright Medical Technology
| Age | 52 |
| Address | Changping Science & Technology Park, Beijing, China |
| Phone | 86 10 6074 5730 |
| Web | https://www.ebmedical.com |
Eyebright Medical Management Efficiency
The company has return on total asset (ROA) of 0.0872 % which means that it generated a profit of $0.0872 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1476 %, meaning that it generated $0.1476 on every $100 dollars invested by stockholders. Eyebright Medical's management efficiency ratios could be used to measure how well Eyebright Medical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Eyebright Medical's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 2.1 B, whereas Non Currrent Assets Other are forecasted to decline to about 107 M.Similar Executives
| Found 4 records | CHAIRMAN Age | ||
| Song Xu | Nuode Investment Co | 42 | |
| Qiang Hou | Tieling Newcity Investment | 48 | |
| Wenhui Lv | AVCON Information Tech | 46 | |
| Wenhui Lu | AVCON Information Tech | 46 | |
Management Performance
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0872 |
Eyebright Medical Leadership Team
Elected by the shareholders, the Eyebright Medical's board of directors comprises two types of representatives: Eyebright Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Eyebright. The board's role is to monitor Eyebright Medical's management team and ensure that shareholders' interests are well served. Eyebright Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Eyebright Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yuqian Zhou, Assistant Secretary | ||
| Jiangbing Xie, GM Chairman | ||
| Zhao Wang, RD GM | ||
| Baoshan Jia, Deputy Director |
Eyebright Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Eyebright Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0872 | ||||
| Profit Margin | 0.27 % | ||||
| Operating Margin | 0.33 % | ||||
| Current Valuation | 17.66 B | ||||
| Shares Outstanding | 189.54 M | ||||
| Shares Owned By Insiders | 38.48 % | ||||
| Shares Owned By Institutions | 20.78 % | ||||
| Price To Book | 7.52 X | ||||
| Price To Sales | 12.64 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Eyebright Stock
Eyebright Medical financial ratios help investors to determine whether Eyebright Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eyebright with respect to the benefits of owning Eyebright Medical security.